1. Breithardt G, Borggrefe M, Wiebringhaus E, Seipel L (1984) Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up. Am J Cardiol 54: 29D
2. Gülker H, Thale J, Olbing B, Heuer H, Frenking B, Bender F (1985) Assessment of the antiarrhythmic profile of the new class I agent diprafenone. Arzneim Forsch 35: 1387
3. Heuer H, Gülker H, Hasfeld M, Frenking B, Behrenbeck Th (1987) Behandlung chronischer ventrikulärer Arrhythmien mit dem neuen Klasse-Ic-Antiarrhythmikum Diprafenon — Ergebnisse der Langzeittherapie. Z Kardiol 76: 415
4. Josephson ME, Seides SF (1979) Clinical cardiac electrophysiology. Techniques and interpretations. Lea & Fibiger, Philadelphia, p 77
5. Kohlhardt M, Seifert C (1983) Tonic and phasic INa blockade by antiarrhythmics. Different properties of drug binding to fast sodium channels as judged from Vmax studies with propafenone and derivatives in mammalian ventricular myocardium. Pflügers Arch 396: 199